Our own recent studies identified the epigenetic regulator KDM3A (JMJD1A/JHDM2A), a member of the Jumonji C domain-containing histone demethylase (JHDM) family [5, 6], as a disease-promoting factor in a pediatric sarcoma. This evidence concerns the gene KDM3A and sarcoma.